You are here: Industry Insights > COVID-19

News List

Contec Launches Virtual Training Tool Sensitive to Social Distancing americanpharmaceuticalreview
March 19, 2020
The ongoing consequences of the novel coronavirus (Covid-19) now include the urgent call for social distancing (meeting postponement, limiting site visitors to facilities, etc.).
The COVID-19 coronavirus epidemic has a natural origin worldpharmanews
March 19, 2020
The novel SARS-CoV-2 coronavirus that emerged in the city of Wuhan, China, last year and has since caused a large scale COVID-19 epidemic ...
FDA Issues Guidance for Conducting COVID-19 Clinical Trials americanpharmaceuticalreview
March 19, 2020
The U.S. Food and Drug Administration (FDA) issued a guidance for industry, investigators and institutional review boards conducting clinical trials during the coronavirus (COVID-19) pandemic.
Clinical programme to evaluate Kevzara® as COVID-19 treatment begins europeanpharmaceuticalreview
March 19, 2020
Led by Sanofi and Regeneron, clinical trials to examine Kevzara (sarilumab) as an effective COVID-19 treatment will begin in the US.
Diatherix Eurofins Launches SARS-CoV-2 Virus Identification Test contractpharma
March 19, 2020
New COVID-19 Panel tests for the SARS-CoV-2 virus along with five bacterial pathogens.
Chinese official says Fujifilm’s Favipiravir could treat Covid-19 pharmaceutical-technology
March 19, 2020
China’s Science and Technology Ministry official Zhang Xinmin has said that Japan-based Fujifilm’s anti-flu drug Favipiravir helped Covid-19 patients recover.
Regeneron identifies several antibodies against Covid-19 pharmaceutical-technology
March 19, 2020
Regeneron Pharmaceuticals has announced the identification of hundreds of fully human antibodies against Covid-19, caused by the novel coronavirus.
SignPath, Relief explore drugs for Covid-19-related ARDS pharmaceutical-technology
March 19, 2020
SignPath Pharma has begun efforts to develop Lipocurc, an intravenous liposomal curcumin formulation, to treat acute respiratory distress syndrome (ARDS) caused by Covid-19.
Covid-19: MannKind, Pneumagen conduct research pharmaceutical-technology
March 19, 2020
MannKind has shifted the research and development (R&D) resources allotted for its lung diseases pipeline to help fight respiratory viral infections, including Covid-19.
Study finds novel coronavirus can remain stable for days pharmaceutical-technology
March 19, 2020
A study led by the US National Institutes of Health found that the novel coronavirus that causes Covid-19 can be viable in air for several hours and on surfaces for days.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page